Company Directory

Oculinea (formerly Zordera), a spin-out company from the University of California, San Francisco, US, is developing proprietary nano-engineered polymer film technology, which has been developed for the long-term delivery of small and large molecule ocular therapeutics.

View Full Profile

Established in 2004, and trusted for its high quality contributions from leading experts, ONdrugDelivery provides 30,000 readers throughout global pharma/biopharma, with pertinent industry information and intelligence about drug delivery-related ideas, technologies, services and products.

View Full Profile

Orbis Biosciences was acquired by Adare Pharmaceuticals in May 2020 and its particle design technology and controlled release delivery systems for oral and injectable products are being integrated into Adare's technology offering. Visit the Adare's profile for latest content and information.

This company is inactive

Otitopic, acquired by tobacco company Philip Morris International in 2021, was a dry powder inhalation company with expertise in formulation and drug delivery device development, including Asprihale^®, a proprietary DPI aspirin formulation for cardiac indications.

This company is inactive

Oval Medical Technologies is a drug delivery device design and development company, specialising in patient-centric autoinjectors. The company develops devices to handle a wide range of formulation requirements, with designs that include proprietary custom primary containers.

View Full Profile

Owen Mumford is a medical device manufacturer that develops products for its own brand and custom device solutions for pharmaceutical and diagnostic companies. Owen Mumford provides research, design and manufacturing capabilities for device production.

View Full Profile

See what ondrugdelivery's readers and contributors think

Matt Kempton
Snr Project Engineer
Corning Incorporated

I am extremely impressed with the comprehensive presentation of information and problem/solution points detailed ... Kudos to you for an extremely well written article with succinct and robust scientific body of knowledge.

Dr Cristian Vilos

I‘m working on the development of microparticles for the release of veterinary antibiotics, and polymeric nanoparticles for siRNA and chemotherapeutic delivery. ONdrugDelivery has been a very usefull platform to connect the scientific research, and marketed drug development.

Donna Bibber
President
Micro Engineering Solutions

I picked up your latest copy at the Boston PODD event and read it with great interest. You’ve really come a long way and you put out an amazingly professional and value-packed magazine.

Li-Chun Tsou, PhD, MBA
Principal Engineer
Merck & Co

Your website and publication is a great asset for me. I’d recommend your publication to my colleagues. I am sure that we will gain knowledge and update information through your timely report. Thanks for making it available.